SANTA ANA, Calif. — – Irvine Scientific , a leading cell culture media/ medical device company for more than 40 years, announced their newly launched cell therapy PRIME-XV product portfolio as part of the company’s commitment to accelerate basic research and clinical applications in cell therapy and regenerative medicine.
